Park National Corp’s Meridian Bioscience Inc VIVO Stock Holding History

Park National Corp’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,450	Closed	-$146K	–	387
2017 Q4	$146K	Hold	10,450	–	–	0.01%	361
2017 Q3	$149K	Hold	10,450	–	–	0.01%	341
2017 Q2	$165K	Hold	10,450	–	–	0.01%	333
2017 Q1	$144K	Sell	10,450 -2,125	-17%	-$29.7K	0.01%	333
2016 Q4	$223K	Sell	12,575 -900	-7%	-$15.8K	0.01%	301
2016 Q3	$260K	Hold	13,475	–	–	0.02%	270
2016 Q2	$263K	Hold	13,475	–	–	0.02%	277
2016 Q1	$278K	Sell	13,475 -900	-6%	-$17.7K	0.02%	265
2015 Q4	$295K	Hold	14,375	–	–	0.02%	247
2015 Q3	$246K	Buy	14,375 +900	+7%	+$16.4K	0.02%	258
2015 Q2	$251K	Hold	13,475	–	–	0.02%	270
2015 Q1	$257K	Buy	13,475 +825	+7%	+$15.3K	0.02%	269
2014 Q4	$208K	Sell	12,650 -2,475	-16%	-$42.5K	0.01%	313
2014 Q3	$268K	Hold	15,125	–	–	0.02%	265
2014 Q2	$312K	Buy	15,125 +1,450	+11%	+$29.8K	0.02%	242
2014 Q1	$298K	Buy	13,675 +1,500	+12%	+$34.4K	0.02%	244
2013 Q4	$323K	Hold	12,175	–	–	0.02%	230
2013 Q3	$288K	Buy	12,175 +275	+2%	+$6.42K	0.02%	240
2013 Q2	$256K	Buy	+11,900	New	+$257K	0.02%	244

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Park National Corp's VIVO Position: Q1 2018 in Review

Park National Corp sold out of Meridian Bioscience Inc (VIVO) in Q1 2018, closing a stake of 10,450 shares — an estimated $146K sold.

Park National Corp first reported a position in VIVO in Q2 2013 and held it in 19 quarters. The position peaked at $323K in Q4 2013. 186 funds tracked by Wall St. Rank hold VIVO as of Q1 2018.

Park National Corp reported no remaining Meridian Bioscience Inc position as of Q1 2018 after selling out during the quarter.
Park National Corp sold 10,450 Meridian Bioscience Inc shares in Q1 2018, an estimated $146K.
Park National Corp first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 19 quarters.
Park National Corp's Meridian Bioscience Inc position peaked at $323K in Q4 2013.
186 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2018.

Based on Park National Corp's 13F filing for Q1 2018, filed 2 Apr 2018.